Ayala Pharmaceuticals EV/Sales

Quel est le EV/Sales de Ayala Pharmaceuticals?

Le EV/Sales de Ayala Pharmaceuticals Inc. est N/A

Quelle est la définition de EV/Sales?

Enterprise value to sales ratio compares a company’s total value to its sales.

ttm (trailing twelve months)

Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.

EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.

EV/Sales des entreprises dans Health Care secteur sur NASDAQ par rapport à Ayala Pharmaceuticals

Que fait Ayala Pharmaceuticals?

advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.

Entreprises avec ev/sales similaire à Ayala Pharmaceuticals

Tissue Repair Ltd a EV/Sales de N/A
Catheter Precision a EV/Sales de N/A
Mirasol Resources a EV/Sales de N/A
Acasti Pharma Inc a EV/Sales de N/A
Pembroke Venture Capital Trust a EV/Sales de N/A
Maven Income & Growth VCT a EV/Sales de N/A
Ayala Pharmaceuticals a EV/Sales de N/A
Yatra Capital a EV/Sales de N/A
SREI Infrastructure Finance a EV/Sales de N/A
Aquarius AI a EV/Sales de N/A
Mobeus Income & Growth 4 VCT plc a EV/Sales de N/A
FAR a EV/Sales de N/A
Clean Power Capital a EV/Sales de N/A